Thomas Kosasa Acquires 1,449,275 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa purchased 1,449,275 shares of the stock in a transaction dated Thursday, July 30th. The shares were acquired at an average cost of $0.69 per share, for a total transaction of $999,999.75. Following the completion of the acquisition, the director directly owned 18,538,150 shares of the company’s stock, valued at approximately $12,791,323.50. This trade represents a 8.48% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Thomas Kosasa also recently made the following trade(s):

• On Friday, June 12th, Thomas Kosasa acquired 158,730 shares of OneMedNet stock. The stock was bought at an average cost of $0.63 per share, with a total value of $99,999.90.
• On Monday, May 18th, Thomas Kosasa acquired 268,817 shares of OneMedNet stock. The stock was bought at an average cost of $0.93 per share, with a total value of $249,999.81.

OneMedNet Stock Down 4.3%

OneMedNet stock traded down $0.03 during trading hours on Friday, hitting $0.62. 1,789,156 shares of the company traded hands, compared to its average volume of 2,223,079. The firm has a market cap of $35.57 million, a P/E ratio of -12.49 and a beta of 1.14. The firm’s 50-day simple moving average is $0.67 and its two-hundred day simple moving average is $0.78. OneMedNet Corporation has a 1-year low of $0.44 and a 1-year high of $4.22.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.04) EPS for the quarter. The business had revenue of $0.10 million for the quarter.

Analyst Ratings Changes

A number of research firms have weighed in on ONMD. Weiss Ratings restated a “sell (e+)” rating on shares of OneMedNet in a research report on Monday, June 1st. Wall Street Zen cut OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.

Institutional Investors Weigh In On OneMedNet

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Exencial Wealth Advisors LLC boosted its position in shares of OneMedNet by 1.3% during the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after purchasing an additional 45,401 shares in the last quarter. State Street Corp grew its stake in shares of OneMedNet by 41.5% in the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock worth $128,000 after purchasing an additional 34,200 shares during the last quarter. Jane Street Group LLC bought a new stake in shares of OneMedNet in the 4th quarter worth approximately $119,000. Virtu Financial LLC acquired a new stake in OneMedNet during the fourth quarter valued at approximately $48,000. Finally, HRT Financial LP bought a new stake in OneMedNet during the fourth quarter worth approximately $32,000. 0.95% of the stock is owned by institutional investors and hedge funds.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.